Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I5ND
|
||||
Former ID |
DIB003732
|
||||
Drug Name |
CNX-010
|
||||
Synonyms |
CNX-010; 11-beta hydroxysteroid dehydrogenase 1 inhibitors (type 2 diabetes), Connexios Life Sciences
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543704] | ||
Company |
Connexios Life Sciences Pvt Ltd
|
||||
Target and Pathway | |||||
Target(s) | Corticosteroid 11-beta-dehydrogenase, isozyme 1 | Target Info | Inhibitor | [543704] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
FSH Signaling Pathway | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.